<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
>

<channel>
	<title>The Next Web</title>
	<atom:link href="https://thenextweb.com/feed" rel="self" type="application/rss+xml" />
	<link>https://thenextweb.com</link>
	<description>Original and proudly opinionated perspectives for Generation T</description>
	<lastBuildDate>Fri, 17 Apr 2026 17:29:16 +0000</lastBuildDate>
	<language>en-US</language>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
	<generator>TNW-API</generator>

	<item>
		<title>Canva becomes the design layer inside Claude with new Anthropic partnership</title>
		<link>https://thenextweb.com/news/canva-anthropic-claude-design-ai-powered-visual-suite</link>
		<pubDate>Fri, 17 Apr 2026 17:11:05 +0000</pubDate>
		<dc:creator><![CDATA[Alina Maria Stan]]></dc:creator>
		<category><![CDATA[Anthropic]]></category>
		<category><![CDATA[Artificial Intelligence]]></category>
		<category><![CDATA[Next Featured]]></category>
		<guid isPermaLink="false">TheNextWeb=6c0edd40bc18715488dd4ed8abb93a60</guid>
		<description><![CDATA[<img src="https://cdn0.tnwcdn.com/wp-content/blogs.dir/1/files/2026/04/canva-anthropic-claude-design-ai-powered-visual-suite.png" width="868" height="488"><br /><p>In short: Canva and Anthropic have launched Claude Design, a new Anthropic Labs product powered by Claude Opus 4.7 that uses Canva’s Design Engine to generate fully editable, on-brand visuals from text descriptions. The announcement coincides with Canva AI 2.0, which the company calls its biggest product launch ever, introducing conversational design, agentic orchestration, and [&hellip;]</p>
<br /><br /><a href="https://thenextweb.com/news/canva-anthropic-claude-design-ai-powered-visual-suite?utm_source=social&utm_medium=feed&utm_campaign=profeed">This story continues</a> at The Next Web]]></description>
		<enclosure url="https://cdn0.tnwcdn.com/wp-content/blogs.dir/1/files/2026/04/canva-anthropic-claude-design-ai-powered-visual-suite.png" type="image/jpeg" length="0" />
	</item>

	<item>
		<title>Allbirds sold its shoe business for $39 million and is pivoting to AI cloud computing</title>
		<link>https://thenextweb.com/news/allbirds-newbird-ai-gpu-compute-pivot-rebrand</link>
		<pubDate>Fri, 17 Apr 2026 17:01:34 +0000</pubDate>
		<dc:creator><![CDATA[Alina Maria Stan]]></dc:creator>
		<category><![CDATA[Artificial Intelligence]]></category>
		<category><![CDATA[Business]]></category>
		<category><![CDATA[Corporates and innovation]]></category>
		<guid isPermaLink="false">TheNextWeb=64668d1db84d47dec7b174f5f6e8f920</guid>
		<description><![CDATA[<img src="https://cdn0.tnwcdn.com/wp-content/blogs.dir/1/files/2026/04/allbirds-newbird-ai-gpu-compute-pivot-rebrand.png" width="868" height="488"><br /><p>In short: Allbirds is rebranding as NewBird AI and pivoting from sustainable footwear to GPU-as-a-service cloud computing after selling its shoe business to American Exchange Group for $39 million. The company secured $50 million in convertible financing, saw its stock surge 600% before falling back by a third, and plans to lease GPUs to AI [&hellip;]</p>
<br /><br /><a href="https://thenextweb.com/news/allbirds-newbird-ai-gpu-compute-pivot-rebrand?utm_source=social&utm_medium=feed&utm_campaign=profeed">This story continues</a> at The Next Web]]></description>
		<enclosure url="https://cdn0.tnwcdn.com/wp-content/blogs.dir/1/files/2026/04/allbirds-newbird-ai-gpu-compute-pivot-rebrand.png" type="image/jpeg" length="0" />
	</item>

	<item>
		<title>Dropbox brings its files, Dash search, and Reclaim calendar into ChatGPT with three new apps</title>
		<link>https://thenextweb.com/news/dropbox-chatgpt-apps-files-dash</link>
		<pubDate>Fri, 17 Apr 2026 10:44:53 +0000</pubDate>
		<dc:creator><![CDATA[Ana Maria Constantin]]></dc:creator>
		<category><![CDATA[Apps]]></category>
		<category><![CDATA[launch]]></category>
		<guid isPermaLink="false">TheNextWeb=9a5f53e2ab71a8853e8a4263deba4b1e</guid>
		<description><![CDATA[<img src="https://cdn0.tnwcdn.com/wp-content/blogs.dir/1/files/2026/04/Dropbox.png" width="868" height="488"><br /><p>The storage company is launching a Dropbox file app, a Dropbox Dash enterprise search app, and a Reclaim AI calendar app inside ChatGPT, letting users access, save, and act on their work without leaving the AI interface. The move is the latest sign that ChatGPT is positioning itself as a productivity operating system, not just [&hellip;]</p>
<br /><br /><a href="https://thenextweb.com/news/dropbox-chatgpt-apps-files-dash?utm_source=social&utm_medium=feed&utm_campaign=profeed">This story continues</a> at The Next Web]]></description>
		<enclosure url="https://cdn0.tnwcdn.com/wp-content/blogs.dir/1/files/2026/04/Dropbox.png" type="image/jpeg" length="0" />
	</item>

	<item>
		<title>ONWARD Medical raises €40.6M to advance its spinal cord stimulation implant</title>
		<link>https://thenextweb.com/news/onward-medical-40-million-eqt-life-sciences</link>
		<pubDate>Fri, 17 Apr 2026 10:28:22 +0000</pubDate>
		<dc:creator><![CDATA[Ana-Maria Stanciuc]]></dc:creator>
		<category><![CDATA[Health Tech]]></category>
		<category><![CDATA[Next Featured]]></category>
		<guid isPermaLink="false">TheNextWeb=8950043fb666e3978db75a11b85e8ff0</guid>
		<description><![CDATA[<img src="https://cdn0.tnwcdn.com/wp-content/blogs.dir/1/files/2026/04/Onward-Medical.png" width="868" height="488"><br /><p>The Eindhoven neurotechnology company is using the proceeds to fund its Empower BP pivotal trial, which tests whether its implantable ARC-IM® system can treat blood pressure instability after spinal cord injury, while expanding commercial rollout of its already-cleared ARC-EX® external therapy system. Cash runway now extends to Q1 2028. ONWARD Medical has raised €40.6 million [&hellip;]</p>
<br /><br /><a href="https://thenextweb.com/news/onward-medical-40-million-eqt-life-sciences?utm_source=social&utm_medium=feed&utm_campaign=profeed">This story continues</a> at The Next Web]]></description>
		<enclosure url="https://cdn0.tnwcdn.com/wp-content/blogs.dir/1/files/2026/04/Onward-Medical.png" type="image/jpeg" length="0" />
	</item>

	<item>
		<title>EU awards its €180 million sovereign cloud contract to four European providers</title>
		<link>https://thenextweb.com/news/eu-sovereign-cloud-180-million-awarded</link>
		<pubDate>Fri, 17 Apr 2026 09:59:10 +0000</pubDate>
		<dc:creator><![CDATA[Ana-Maria Stanciuc]]></dc:creator>
		<category><![CDATA[Europe]]></category>
		<category><![CDATA[Insider]]></category>
		<category><![CDATA[Next Featured]]></category>
		<guid isPermaLink="false">TheNextWeb=2d8453010e186ae682f9f17f5819c934</guid>
		<description><![CDATA[<img src="https://cdn0.tnwcdn.com/wp-content/blogs.dir/1/files/2026/04/EU-1.png" width="868" height="488"><br /><p>Post Telecom (with CleverCloud and OVHcloud), StackIT, Scaleway, and Proximus (with S3NS, a Thales – Google Cloud joint venture, plus Clarence and Mistral) have won the European Commission’s six-year sovereign cloud framework contract. The Proximus consortium’s inclusion signals that non-European technology can qualify as ‘sovereign’ under the Commission’s framework if operated within a sufficiently strict [&hellip;]</p>
<br /><br /><a href="https://thenextweb.com/news/eu-sovereign-cloud-180-million-awarded?utm_source=social&utm_medium=feed&utm_campaign=profeed">This story continues</a> at The Next Web]]></description>
		<enclosure url="https://cdn0.tnwcdn.com/wp-content/blogs.dir/1/files/2026/04/EU-1.png" type="image/jpeg" length="0" />
	</item>

	<item>
		<title>DeepL launches real-time voice-to-voice translation in 40+ languages</title>
		<link>https://thenextweb.com/news/deepl-voice-to-voice-real-time-spoken-translation</link>
		<pubDate>Fri, 17 Apr 2026 09:11:42 +0000</pubDate>
		<dc:creator><![CDATA[Ana-Maria Stanciuc]]></dc:creator>
		<category><![CDATA[launch]]></category>
		<category><![CDATA[Apple]]></category>
		<guid isPermaLink="false">TheNextWeb=dd2ef4ba0b50fa5577adf16e0e5c0448</guid>
		<description><![CDATA[<img src="https://cdn0.tnwcdn.com/wp-content/blogs.dir/1/files/2026/04/DeepL.png" width="868" height="488"><br /><p>The Cologne-based translation company best known for its text tools has unveiled a full voice product suite covering meetings, conversations, group settings, and an API for enterprise integration. A live demo in Seoul showed one-to-two sentence delays, and DeepL’s CPO acknowledged word order differences between languages remain a fundamental challenge. DeepL, the Cologne-based language AI [&hellip;]</p>
<br /><br /><a href="https://thenextweb.com/news/deepl-voice-to-voice-real-time-spoken-translation?utm_source=social&utm_medium=feed&utm_campaign=profeed">This story continues</a> at The Next Web]]></description>
		<enclosure url="https://cdn0.tnwcdn.com/wp-content/blogs.dir/1/files/2026/04/DeepL.png" type="image/jpeg" length="0" />
	</item>

	<item>
		<title>AlixLabs closes €15M Series A to commercialise the atomic etching technology</title>
		<link>https://thenextweb.com/news/alixlabs-15m-series-a-aps-atomic-etching-semiconductor</link>
		<pubDate>Fri, 17 Apr 2026 08:56:30 +0000</pubDate>
		<dc:creator><![CDATA[Cristian Dina]]></dc:creator>
		<category><![CDATA[Startups and technology]]></category>
		<category><![CDATA[Deep tech]]></category>
		<category><![CDATA[Next Featured]]></category>
		<guid isPermaLink="false">TheNextWeb=6b38b5a8d3538040510ce7edc3bfd418</guid>
		<description><![CDATA[<img src="https://cdn0.tnwcdn.com/wp-content/blogs.dir/1/files/2026/04/AlixLabs.png" width="868" height="488"><br /><p>AlixLabs, the Lund-based semiconductor process startup developing Atomic Pitch Splitting (APS™), has completed its €15M Series A with a strategic top-up from Finnish investor Stephen Industries. The company is targeting beta testing with chipmakers in 2026 and manufacturing deployment by 2027. AlixLabs, a deep-tech semiconductor startup based in Lund, Sweden, has closed its €15 million [&hellip;]</p>
<br /><br /><a href="https://thenextweb.com/news/alixlabs-15m-series-a-aps-atomic-etching-semiconductor?utm_source=social&utm_medium=feed&utm_campaign=profeed">This story continues</a> at The Next Web]]></description>
		<enclosure url="https://cdn0.tnwcdn.com/wp-content/blogs.dir/1/files/2026/04/AlixLabs.png" type="image/jpeg" length="0" />
	</item>

	<item>
		<title>Ericsson narrowly misses Q1 profit forecasts as North America unwind</title>
		<link>https://thenextweb.com/news/ericsson-q1-2026-results-north-america</link>
		<pubDate>Fri, 17 Apr 2026 08:09:15 +0000</pubDate>
		<dc:creator><![CDATA[Ana-Maria Stanciuc]]></dc:creator>
		<category><![CDATA[Business]]></category>
		<guid isPermaLink="false">TheNextWeb=1248733c19d53d6dd0da981c5a99b98a</guid>
		<description><![CDATA[<img src="https://cdn0.tnwcdn.com/wp-content/blogs.dir/1/files/2026/04/Ericsson.png" width="868" height="488"><br /><p>The Swedish telecoms equipment maker narrowly missed profit forecasts, with adjusted EBITA falling 20% year-on-year to SEK 5.6 billion. North America, which drove a 20%+ surge in Q1 2025, declined sharply as prior-year pull-forward investment unwinds. CEO Ekholm blames rising semiconductor input costs, partly driven by AI demand. Ericsson reported a sharp fall in profitability [&hellip;]</p>
<br /><br /><a href="https://thenextweb.com/news/ericsson-q1-2026-results-north-america?utm_source=social&utm_medium=feed&utm_campaign=profeed">This story continues</a> at The Next Web]]></description>
		<enclosure url="https://cdn0.tnwcdn.com/wp-content/blogs.dir/1/files/2026/04/Ericsson.png" type="image/jpeg" length="0" />
	</item>

	<item>
		<title>OpenAI launches GPT-Rosalind, a specialised AI model for drug discovery and life sciences research</title>
		<link>https://thenextweb.com/news/openai-gpt-rosalind-life-sciences-drug-discovery-ai-model</link>
		<pubDate>Fri, 17 Apr 2026 07:51:49 +0000</pubDate>
		<dc:creator><![CDATA[Ana Maria Constantin]]></dc:creator>
		<category><![CDATA[Artificial Intelligence]]></category>
		<category><![CDATA[Science]]></category>
		<category><![CDATA[Next Featured]]></category>
		<guid isPermaLink="false">TheNextWeb=4fb9a359446298e0b5912478808dc7e5</guid>
		<description><![CDATA[<img src="https://cdn0.tnwcdn.com/wp-content/blogs.dir/1/files/2026/04/GPT-Rosalind.png" width="868" height="488"><br /><p>Named after the crystallographer who helped reveal the structure of DNA, GPT-Rosalind is OpenAI’s first domain-specific model series, fine-tuned for biochemistry, genomics, and protein engineering. Access is restricted to a trusted-access programme for vetted enterprise customers including Amgen, Moderna, and Thermo Fisher Scientific. OpenAI has launched GPT-Rosalind, a frontier reasoning model built specifically for life [&hellip;]</p>
<br /><br /><a href="https://thenextweb.com/news/openai-gpt-rosalind-life-sciences-drug-discovery-ai-model?utm_source=social&utm_medium=feed&utm_campaign=profeed">This story continues</a> at The Next Web]]></description>
		<enclosure url="https://cdn0.tnwcdn.com/wp-content/blogs.dir/1/files/2026/04/GPT-Rosalind.png" type="image/jpeg" length="0" />
	</item>

	<item>
		<title>Stockholm’s BioLamina secures €20M EIB loan to scale the protein matrices that make cell therapies possible</title>
		<link>https://thenextweb.com/news/biolamina-20m-eib-loan-laminin-cell-therapy</link>
		<pubDate>Fri, 17 Apr 2026 07:34:12 +0000</pubDate>
		<dc:creator><![CDATA[Ana-Maria Stanciuc]]></dc:creator>
		<category><![CDATA[Health Tech]]></category>
		<category><![CDATA[Europe]]></category>
		<category><![CDATA[Next Featured]]></category>
		<guid isPermaLink="false">TheNextWeb=cb898cb7d00ae81f0d2cb429f42aedae</guid>
		<description><![CDATA[<img src="https://cdn0.tnwcdn.com/wp-content/blogs.dir/1/files/2026/04/BioLamina.png" width="868" height="488"><br /><p>The European Investment Bank is lending €20 million to BioLamina, the Swedish biotech that supplies the laminin-based cell culture matrices used by stem cell therapy developers worldwide. The funding will support expanded production of laminin technologies and animal-free drug safety testing methods. BioLamina, the Stockholm-based biotechnology company that produces the protein scaffolding used to grow [&hellip;]</p>
<br /><br /><a href="https://thenextweb.com/news/biolamina-20m-eib-loan-laminin-cell-therapy?utm_source=social&utm_medium=feed&utm_campaign=profeed">This story continues</a> at The Next Web]]></description>
		<enclosure url="https://cdn0.tnwcdn.com/wp-content/blogs.dir/1/files/2026/04/BioLamina.png" type="image/jpeg" length="0" />
	</item>

</channel>
</rss>